Fresenius Medical Care AG & Co. KGaA (ADR) (NYSE:FMS)

CAPS Rating: 5 out of 5

The Company is engaged in the manufacture and sale of products for all forms of kidney dialysis, to health care providers throughout the world, and in providing kidney dialysis treatment and other medical ancillary services.

Recs

0
Player Avatar emeraldinv (48.76) Submitted: 11/8/2008 3:35:46 PM : Outperform Start Price: $42.41 FMS Score: +15.26

Regular profit gain over last several years continued through 2008. Expect improving profits to continue with expanding health care.

Featured Broker Partners


Advertisement